Rountree C Bart, Wang Xuli, Ge Shundi, Barsky Lora, Zhu Judy, Gonzales Ignacio, Crooks Gay M
Division of Gastroenterology, Hepatology, and Nutrition, Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA.
Hepatology. 2007 May;45(5):1250-60. doi: 10.1002/hep.21600.
Recent reports have provided conflicting conclusions regarding the role for bone marrow (BM)-derived cells in the regeneration of liver. Our aim was to investigate the potential of BM to contribute to liver epithelium using different BM transplant models designed to explore differentiation during normal liver development and regeneration after toxic injury. BM cells from transgenic green fluorescent protein (GFP) mice were injected into neonatal and adult immunodeficient and neonatal immune-competent mice. Three distinct models of liver injury were employed to test the contribution of marrow to the regeneration of hepatocytes, cholangiocytes, and oval cells in immune-deficient adult animals after neonatal transplant. Immunohistochemistry was combined with flow cytometry (FACS) and reverse transcription (RT)-PCR to increase the sensitivity and specificity of the analyses. Although GFP+ marrow-derived cells were observed in the livers of all transplanted animals, immunohistochemistry failed to demonstrate any marrow derived hepatocytes or cholangiocytes. FACS confirmed that GFP+ marrow-derived cells in the liver maintained expression of CD45, a leukocyte marker. Gene expression studies of GFP+ cells isolated by FACS failed to demonstrate expression of liver specific genes in these marrow-derived cells.
Through highly sensitive and specific analyses, we were unable to demonstrate any evidence of transdifferentiation of BM-derived cells into epithelial hepatic tissue during the period of rapid growth in the neonatal period. Furthermore, although increased migration of hematopoietic cells to the liver occurred after toxic injury, these cells did not contribute directly to the replacement of hepatocytes, cholangiocytes, or oval cells.
最近的报告对于骨髓(BM)来源的细胞在肝脏再生中的作用得出了相互矛盾的结论。我们的目的是利用不同的BM移植模型来研究BM对肝上皮细胞的潜在贡献,这些模型旨在探索正常肝脏发育过程中的分化以及毒性损伤后的再生。将来自转基因绿色荧光蛋白(GFP)小鼠的BM细胞注射到新生和成年免疫缺陷小鼠以及新生免疫健全小鼠体内。采用三种不同的肝损伤模型来测试新生移植后免疫缺陷成年动物中骨髓对肝细胞、胆管细胞和卵圆细胞再生的贡献。免疫组织化学与流式细胞术(FACS)和逆转录(RT)-PCR相结合,以提高分析的敏感性和特异性。尽管在所有移植动物的肝脏中都观察到了GFP+骨髓来源的细胞,但免疫组织化学未能证明有任何骨髓来源的肝细胞或胆管细胞。FACS证实肝脏中GFP+骨髓来源的细胞维持白细胞标志物CD45的表达。对通过FACS分离的GFP+细胞进行的基因表达研究未能证明这些骨髓来源的细胞中存在肝脏特异性基因的表达。
通过高度敏感和特异的分析,我们未能证明在新生期快速生长期间有任何证据表明BM来源的细胞转分化为肝上皮组织。此外,尽管毒性损伤后造血细胞向肝脏的迁移增加,但这些细胞并未直接参与肝细胞、胆管细胞或卵圆细胞的替代。